Rehydration Oral Powder
Natural health product licensed in Canada
- Licence holder
- BIOVANTEK
- NPN or DIN-HM
- 80072454
- Status
- Inactive licence
- Licence date
- 9 September 2016
- Revision date
- 18 May 2022
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Potassium Source : Citrate de potassium | 170 milligramme | Not calculated |
| Chlorure (ion) Source : Citrate de potassium | 400 milligramme | Not calculated |
| Chlorure (ion) Source : Citrate de sodium | 400 milligramme | Not calculated |
| Citrate Source : Citrate de sodium | 470 milligramme | Not calculated |
| Citrate Source : Citrate de potassium | 470 milligramme | Not calculated |
| Sodium Source : Chlorure de sodium | 330 milligramme | Not calculated |
| Sodium Source : Citrate de sodium | 330 milligramme | Not calculated |
| D-glucose Source : Glucose | 3,500 milligramme | Not calculated |
Non-medicinal ingredients
Dioxyde de silicium, Saveur, Sucralose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 1 packet ; maximum: 4 packet | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to maintain fluid and electrolyte balance in cases of vomiting and/or diarrhoea.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Continue to give/take solution until diarrhoea stops. Consult a health care practitioner if diarrhoea/vomiting worsen or persist longer than 24 hours. Consult a health care practitioner if signs of dehydration occur: changes in mental status such as irritability, lack of interest of inactivity, reduced urine output, dry mouth, increased heart and/or breathing rate, decreased tears and/or sunken eyes. Consult a health care practitioner if signs of electrolyte imbalance occur such as: disproportionate thirst, muscle weakness, or swelling of the hands, face and/or feet. Consult a health care practitioner if diarrhoea contains blood or mucous, is accompanied by a high fever, yellowing of eye or skin, or persistent vomiting, if vomit is green or contains blood, is accompanied by severe abdominal pain, a high fever or if a bowel obstruction is suspected. If you have a gastrointestinal obstruction, cardiovascular or kidney disease, consult a health care practitioner prior to use.
- Contre-indications
Not to be used following vigorous exercise or acute dehydration (unless administered with an appropriate balance of other mineral salts, e.g. sodium). Do not use is you have adrenal insufficiency or uncontrolled diabetes mellitus. Do not use if you are taking prescription medications especially those which increase serum potassium such as potassium-sparing diuretics or angiotensin converting enzyme (ACE) inhibitors. Do not use with other potassium-containing supplements or with potassium-containing salts substitutes. Do not use if you have gastrointestinal ulceration or obstruction.
- Effets indésirables connus
May cause nausea, vomiting, diarrhoea, abdominal cramps; discontinue use and consult a health care practitioner if these symptoms are severe.
Source
Official Health Canada record, licence 80072454
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2022. Photograph the packaging to check whether it has changed. Photograph the packaging